Position in PFE
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$17,916,338
-$4,240,242 QoQ
Shares Held
744,034
-5.7% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#313
of 2,820 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Dec 31, 2023CallValue
$18,200
CallShares
7,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Private Advisor Group, LLC holds $233,466,304 across 14 Drug Manufacturers - General names. PFE ranks #5 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
277,688 | $70,524,421 | |
| 2 | ABBV |
AbbVie Inc.
|
233,214 | $58,685,970 | |
| 3 | MRK |
Merck & Co., Inc.
|
266,566 | $34,253,731 | |
| 4 | AMGN |
Amgen Inc
|
55,311 | $20,029,219 | |
| 5 | PFE |
Pfizer Inc
This page
|
744,034 | $17,916,338 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
194,227 | $11,191,359 | |
| 7 | AZN |
Astrazeneca PLC
|
30,398 | $5,764,068 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
43,759 | $5,528,512 |
All Filings in PFE
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,916,338 | 744,034 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $22,156,580 | 789,052 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $19,464,628 | 781,712 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $17,286,039 | 678,416 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $16,897,582 | 697,095 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $17,933,472 | 707,714 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $17,655,078 | 665,476 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $24,586,989 | 849,585 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $20,592,216 | 735,962 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $18,098,772 | 652,208 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $16,440,241 | 571,040 | Shares | Sole | 2024-02-06 | |
| 2023-12-31 | $18,200 | 7,000 | Call | Sole | 2024-02-06 | |
| 2023-09-30 | $27,298 | 82,300 | Call | Sole | 2023-11-03 | |
| 2023-09-30 | $19,593,021 | 590,685 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $22,469,214 | 612,574 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $23,132,947 | 566,984 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $29,087,000 | 567,662 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $26,911,218 | 614,973 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $37,366,913 | 712,701 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $35,686,251 | 689,323 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $46,368,008 | 785,233 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $17,204 | 400 | Call | Sole | 2021-10-14 | |
| 2021-09-30 | $38,405,177 | 892,936 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $24,328,463 | 621,258 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $24,547,708 | 677,552 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $23,014,274 | 625,218 | Shares | Sole | 2021-04-01 | |
| 2020-09-30 | $18,779,738 | 511,710 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $15,688,527 | 479,771 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $13,953,222 | 427,489 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||